Literature DB >> 7254516

Comparison of CVA imaging with 99mTc phosphates, 99mTc pertechnetate, and computed tomography.

D S Schauwecker, R W Burt, B D Richmond.   

Abstract

A retrospective study was made of 111 patients who underwent computed tomography (CT) and nuclear brain scans, with both pertechnetate and phosphate bone agents (PHOS), within 7 days of each other. Specifically, 78 patients who had a recent cerebral vascular accident (CVA) were compared. There were no significant sensitivity differences between the methods. While these studies appear complementary, the most important criterion is the time after onset when the studies were performed. The axiom "if the intensity of the phosphate scan exceeds that of the pertechnetate, the lesion must be a CVA" is true, only if the study is performed within 4 weeks of onset. The most economical method for optimum detection of CVA, with avoidance of frequent errors, is an early CT followed by a PHOS brain scan about 14 days after ictus in those that have initial negative CT.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7254516     DOI: 10.1007/bf00367341

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  17 in total

1.  Computed tomography and brain scintigraphy in ischemic stroke.

Authors:  L C Chiu; L B Fodor; S H Cornell; J H Christie
Journal:  AJR Am J Roentgenol       Date:  1976-09       Impact factor: 3.959

2.  Positive brain scans in children with idiopathic focal epileptic seizures.

Authors:  A L Prensky; C N Swisher; D C DeVivo
Journal:  Neurology       Date:  1973-08       Impact factor: 9.910

3.  Uptake of 99mTc-stannous polyphosphate in an area of cerebral infarction.

Authors:  W W Wenzel; R G Heasty
Journal:  J Nucl Med       Date:  1974-03       Impact factor: 10.057

4.  Mitochondrial mineralization in human myocardium.

Authors:  A N D'Agostino; M Chiga
Journal:  Am J Clin Pathol       Date:  1970-06       Impact factor: 2.493

5.  Comparison of computerized tomography and radionuclide imaging in "stroke".

Authors:  M H Gado; R E Coleman; A L Merlis; P O Alderson; K S Lee
Journal:  Stroke       Date:  1976 Mar-Apr       Impact factor: 7.914

6.  Brain scanning in cerebral vascular disease: a reappraisal.

Authors:  D M Welch; R E Coleman; W B Hardin; B A Siegel
Journal:  Stroke       Date:  1975 Mar-Apr       Impact factor: 7.914

7.  Computed tomography and radionuclide imaging in the evaluation of ischemic stroke.

Authors:  J K Campbell; O W Houser; J C Stevens; H W Wahner; H L Baker; W N Folger
Journal:  Radiology       Date:  1978-03       Impact factor: 11.105

8.  Optimal utilization of computerized cranial tomography and radionuclide brain imaging.

Authors:  P O Alderson; M Mikhael; R E Coleman; M Gado
Journal:  Neurology       Date:  1976-09       Impact factor: 9.910

9.  Cerebral infarction: a disparity between Tc-99m-pertechnetate and Tc-99m-EHDP images.

Authors:  H Mori; T Maeda; K Hisada; S Kobayashi
Journal:  Clin Nucl Med       Date:  1980-07       Impact factor: 7.794

10.  Localization of technetium-99m diphosphonate in acutely injured muscle. Relationship to muscle calcium deposition.

Authors:  B A Siegel; W K Engel; E C Derrer
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

View more
  1 in total

1.  Tumour-like thallium-201 accumulation in brain infarcts, an unexpected finding on single-photon emission tomography.

Authors:  I Bernat; G Toth; L Kovács
Journal:  Eur J Nucl Med       Date:  1994-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.